Ranolazine 70625-0206
Product NDC
70625-0206- Manufacturer
- Sungen Pharma Llc
- Dosage Form
- Tablet, Film Coated, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- April 1, 2020
- Listing Expires
- December 31, 2027
- Application
- ANDA212781
Need to source Ranolazine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ranolazine | 500 mg/1 |
Drug Class
Anti-anginal [EPC]Anti-anginal [EPC]Cytochrome P450 2D6 Inhibitors [MoA]
Packaging Options(3)
29125 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOX (70625-206-00)
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70625-206-01)
500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70625-206-02)